Abstract

The two studies assessing the safety and efficacy of high-dose nicotine patch therapy by Jorenby et al 1 and Dale et al 2 in this issue ofTHE JOURNALraise four questions: Should higher-dose nicotine patches be used? Should nicotine patch therapy be tailored to achieve 100% replacement? How effective is the nicotine patch when given with no physician advice, ie, in over-the-counter—like conditions, in comparison with its effectiveness with physician advice, in prescription-like conditions? How much is its efficacy increased by adding behavioral therapy? See also pp 1347 and 1353. Dale et al 2 found that 22-mg patches underdose the majority of smokers and that higher doses are safe, provide better withdrawal relief, and appear to increase efficacy. Their results are supported by other studies, which found that standard-dose patches (15 to 22 mg/d) provide less than 100% nicotine replacement 3 ; greater nicotine replacement decreases withdrawal symptoms and increases

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.